Today's Information |
Provided by: EirGenix Inc. | |||||
SEQ_NO | 3 | Date of announcement | 2022/08/11 | Time of announcement | 18:10:14 |
Subject | Announcement of the Construction Design and Consulting Fee for New Plant. | ||||
Date of events | 2022/08/11 | To which item it meets | paragraph 20 | ||
Statement | 1.Type of contract:Construction Design and Consulting Fee. 2.Date of occurrence of the event:2022/08/11 3.Counterparty to the contract and relationship with the Company: Facility construction design companies and consultant companies. Relationship with the Company: None. 4.Major content of the contract (including total contract amount, anticipated monetary amount of participation in the investment, and start and end dates of the contract), restrictive covenants, and other important terms and conditions: Total contract amount: The upper limit is NT$0.45 billion (tax and exchange difference included) Start and end dates of the contract: From the signing date to the completion date of the new plant construction design. Restrictive covenants: None. Other important terms and conditions: None. 5.Name of the professional appraisal firm or company and its appraisal opinion:N/A 6.Name of the real property appraiser:N/A 7.Practice certificate number of the real property appraiser:N/A 8.Concrete purpose of the acquisition: To prepare for the growth of the CDMO business and the commercial needs of internal development products, the company plans to build up a large-scale mammalian cell culture facility of 150,000L split into three stages within 6 to 8 years' time. 9.Any dissenting opinions of directors to the present transaction:None. 10.Whether the counterparty of the current transaction is a related party:No. 11.Date of the board of directors' resolution:2022/08/11 12.Date of ratification by supervisors or approval by the audit committee:2022/08/11 13.The appraisal report has a limited price, specific price, or special price:NA 14.An appraisal report has not yet been obtained:NA 15.Reason for an appraisal report not being obtained:N/A 16.Reason for any significant discrepancy with the appraisal reports and opinion of the CPA:N/A 17.Name of the CPA firm:N/A 18.Name of the CPA:N/A 19.Practice certificate number of the CPA:N/A 20.29.Any other matters that need to be specified:None. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
EirGenix Inc. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 10:23:04 UTC.